Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer (NCT04576091) | National Cancer Institute (NCI) | 2022-07-06 |
Track Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.